Safety concerns and/or the stochastic nature of current transduction approaches have hampered clinical translation of nuclear reprogramming. We report a novel non-viral nanotechnology-based platform permitting deterministic large-scale transfection with single-cell resolution. The superior capabilities of our technology are demonstrated by modification of the well-established direct neuronal reprogramming paradigm using overexpression of the transcription factors Brn2, Ascl1, and Myt1l (BAM). Reprogramming efficiencies were comparable to viral methodologies (up to ~9-12%) without the constraints of capsid size and with the ability to control plasmid dosage, in addition to showing superior performance relative to existing non-viral methods. Furthermore, increased neuronal complexity could be tailored by varying BAM ratio and by including additional proneural genes to the BAM cocktail.
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Background
Directly inducing a specific cell fate requires not only the knowledge of which factors can stably induce a desired cell type, but also the ability to introduce these exogenous genes/proteins into cells in a controlled fashion. As has been elegantly demonstrated, nuclear reprogramming methodologies typically require relatively small cocktails of transcription factors to change a cell's epigenetic framework. For example, exogenous expression of OCT4, KLF4, SOX2, and cMYC reprograms fibroblasts into induced pluripotent stem (iPS) cells 1 . In addition, direct nuclear reprogramming of fibroblasts into post-mitotic neurons has been demonstrated by the forced expression of Ascl1, Brn2, and Myt1l 2 . These technologies provide significant opportunities to improve human health by advancing our understandings of basic cell biology, by facilitating the modeling of human diseases for pre-clinical drug development pipelines, and, ultimately, for clinically-relevant cell therapies.
For regenerative medicine and disease modeling applications, it may be more desirable to induce cells directly to the lineage of interest rather than by first proceeding through an iPS cell stage. This represents a unique challenge in cases where the cell of interest is post-mitotic and underscores the need to discover deterministic transfection methodologies for reprogramming applications. For example, to obtain a high quantity of neurons from direct neuronal reprogramming of dermal fibroblasts, a large number of cells would have to undergo the reprogramming process deterministically. Such reprogramming strategies would require the ability to control the transdifferentiation of large numbers of cells. Although significant advances have been made in reprogramming paradigms, including the implementation of small molecules and pharmaceutical approaches 3 4-7 , the ability to directly control the dosage of reprogramming factors in each individual cell has not yet been achieved. Furthermore, the stochastic barriers to implementing this long term vision have not been identified.
The most widely implemented non-viral transfection approaches depend upon diffusion-and endocytosis-based mechanisms, resulting in stochastic transfections 8 . We have overcome this problem by developing a novel and easy-to-use device that permits in situ electroporation on cultured cells through a 3D ordered array of nanochannels. Such an array was created via the adaptation of conventional transwell inserts, which are commonly used in routine cell culture, for nanochannel electroporation (NEP). NEP is a single-cell transfection system that electrophoretically delivers charged agents directly into the cytosol by applying an intense electric field over a small area of the cell membrane 9 , thus facilitating precise dosage control with minimum cell damage. A significant advantage of NEP over other electroporation paradigms is the benign nature of the transfection, resulting in negligible perturbations to cell physiology 9 . Although other electroporation modalities have similarly demonstrated enhanced transfection control of various types of engineered molecules with minimal cell toxicity 10, 11 , deterministic transfection technologies for nuclear reprogramming applications has remained elusive. We validated the superiority of our novel NEP platform with a well-established direct nuclear reprogramming model that involves fibroblast transdifferentiation into neurons by exogenous expression of Brn2, AsclI, and Myt1l (BAM). We found that the NEP platform was superior to BEP with regards to reprogramming efficiency, showing iN generation at levels comparable to reports using lentivirus. Moreover, due to the inherent deterministic advantages of the NEP methodology, we were also able to demonstrate that nuclear reprogramming by BAM is regulated by AsclI dosage, is regulated by the S-phase cyclin CCNA2, can be enhanced by adding proneural genes to the NEP cocktail, and that at least some neurons induced through BAM-mediated neuronal reprogramming may pass through a nestin-positive cell stage.
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NEP Platform Fabrication:
Unmodified transwell inserts possess a highly dense and random array of nanochannels whose interactions with plated cells cannot be controlled at the single cell level. This could potentially result in high intercellular variability in the transfection characteristics among other things. Using standard cleanroom technologies (Fig. 1, Fig. S1 ), the apical or basal surface of the Transwells were spin coated (CE 100CB Resist Coater) with positive photoresist (S1813 or SPR-220.7) at ~3000 rpm for 1 min. The devices were subsequently soft-baked at room temperature for >16 h. The resist was then controllably exposed to UV light through a dark field photomask with circular openings of varying diameters using a contact aligner (EV Group 620 Advanced Contact Aligner). Following exposure, the photoresist was developed in positive resist developer for 1-2 min, which exposed the underlying nanopores on the Transwell membrane in an arrayed and orderly manner. Further details of the fabrication procedure are presented in the supplemental materials.
Cell Culture and Transfections:
BEP-based transfection: A Neon (Life Technologies) transfection system was used for BEP transfection. The cells were resuspended at a final concentration of 1.0x10^6 cells, in 0.1 ml. The cell suspension was then mixed with the plasmid (0.05-0.1 µg/µl) solution, and the tip was then inserted into the Neon tube containing the electrolytic buffer. The cells were electroporated following a protocol suggested by the manufacturer (one 30 ms pulse of 1350 V) optimized for MEF cells. BEP-based transfection outside these conditions could result in reduced efficacy and/or increased MEF cell death.
NEP-based transfection:
MEF cells were directly loaded on the entire apical surface of the Transwell membrane at a density of ~1.0-1.5 x 10 4 cells/cm 2 in regular maintenance medium (Fig. 1A) . The cells were allowed to adhere and spread overnight before NEP transfection.
Alternatively, cells could be selectively plated directly on top of the exposed nanochannels on the apical surface of the Transwell by controllably applying dielectrophoretic forces across the Transwell (Fig. S1) . Following cell loading, the media in the apical chamber was replaced by PBS and the Transwell inserts were then mounted on an e-beam evaporated (Denton DV-502A E-Gun Evaporator) gold electrode that was in direct contact with the plasmid solution (Fig. 1C) . A counter-electrode was then immersed in the PBS of the apical chamber, and a square wave pulse (250 V, 20 ms duration pulse, 1-10 pulses) was applied across the electrodes using a Biorad Gene Pulser Xcell power supply. The PBS was replaced by fresh media immediately after, and the cells were then incubated overnight at 37 C.
Induced Neuron protocol: Post-NEP, MEF's were cultured in N3 media. N3 neuronal induction medium was prepared by supplementing DMEM/F-12 (Invitrogen) base media with 25 μg/ml bovine insulin, 30 nmol/l sodium selenite, 50 μg/ml human apo-transferrin, 20 nmol/l progesterone, 10 ng/ml human bFGF2, and 100 μmol/l putrescine.
Statistical Analysis
All statistics were performed in Rv2.12, Microsoft Excel, and Matlab. Sholl analysis and dendrite complexity index were performed using Neurolucida Explorer TM v11.
Results
An easy-to-use platform for deterministic large scale cell transfection Fig. 1A illustrates the device design. Briefly, an array of nano-to micro-scale wells were patterned on the nanochanneled transwell membrane surface to (i) minimize cytotoxic currents during electrotransfection, and (ii) to better control the extent of interaction of single cells with the nanoporating channels (Fig. S1A) . This in turn leads to controlled dosage at the single cell level. The cells are then loaded on the apical surface, which is subsequently mounted within a pair of electrodes over a reservoir containing the cargo solution (Fig. 1C) . A square wave DC pulse with a 250 V amplitude and a 20 ms pulse duration is then applied across the electrodes to porate the cells (Fig. 1D-G (Fig. S1P) . Moreover, NEP conditions could be easily tailored to control the dosage (Fig.   S1P3) . We compared NEP-treated cells with the upper 2% BEP-transfected cells (as sorted by FACS of GFP-positive cells) and found that even though the mean RFU of this BEP subset was similar to that of the NEP 5-pulse group, the NEP-treated cells had improved viability and a smaller interquartile range in RFU relative to the BEP cells (Fig. S1Q) . The top 2% BEP cells were viable for less than 2 days.
Co-expression of all three plasmids was detected 24h after transfection. When comparing GFP/RFP/CFP-positive cells, NEP 5-pulse resulted in significantly higher mean relative fluorescence expression compared to BEP (Fig. 1H-J) . Moreover, the fluorescence intensity variance among NEP-treated cells was significantly lower compared to BEP. In addition, while all the clones in the NEP group had a tendency to successfully co-express all three plasmids, a host of cells in the BEP group only showed detectable expression of one or two of the three plasmids ( Fig. 1 H1-J1 arrowheads) . Persistent long-term expression of BAM reporter constructs was seen in a number of cells in the NEP group (Fig. 2) . This was further confirmed by in vivo studies in which MEFs underwent NEP of BAM prior to being subcutaneously injected into E15.5 embryos in utero. Postnatal day 4 pups that had undergone embryonic transplanation showed significant GFP expression by in vivo IVIS imaging ( Fig. 2) compared to control pups.
We conclude that NEP-based transfection results in stronger and more uniform gene expression compared to BEP, and that such expression showed stable and long-lasting behavior both in vitro and in vivo.
Deterministic NEP-based transfection leads to efficient and controlled transfection
In order to further test the effects of a more deterministic transfection approach in reprogramming outcome, we cultured the transfected MEFs in N3 media for a prolonged period of time and monitored induced neuron (iN) formation by assaying neuronal marker expression, morphological changes, and electrophysiological activity. NEP-treated cultures showed significantly higher and more narrowly-distributed early (day 7) reprogramming efficiencies (based on number of TUJ1+ cells) across samples compared to BEP (Fig. 3A) . Following transfection, a number of NEP-treated cells started to show significant morphological changes compatible with neuronal transformation within remarkably short timeframes (<48 h, Supplementary Video 1), exhibiting slightly faster kinetics compared to viral infection 2 . NEP of human dermal fibroblasts with BAM plasmids also showed rapid morphological changes suggestive of reprogramming (Fig. S1R) . Mature neuronal marker (MAP2, synapsin and neurofilament) expression in the NEP group was similarly detected very early post-NEP (week 1). Moreover, NEP-treated cells also showed electrophysiological activity as demonstrated by their capacity to undergo induced action potentials ( Fig. 3E- 
H).
A single NEP-based transfection was enough to reprogram a higher proportion of iNs in a shorter period of time compared to previous reports on non-viral iN reprogramming 13 .
Nevertheless, a relatively large proportion of MEFs still had not shown signs of iN reprogramming at our experimental end-points. We hypothesized that this was partly due to the fact that Ascl1 plasmid expression appears to be rapidly and selectively silenced in a number of MEF cells (Supplementary Video 2). Brn2 and Myt1l expression on the other hand seemed to be less prone such silencing.
We therefore increased the dosage of Ascl1 relative to Brn2 and Myt1l in NEP so as to determine a more optimal dosage of BAM cDNA expression plasmids for neuronal reprogramming. The current status quo for controlling molar ratios of reprogramming genes is to deliver them in a multicistronic expression plasmid 12 or implement TEVP-mediated proteolytic cleavage 14 . We found that increasing the relative molar ratio of Ascl1 to 2:1:1 (Ascl1:Brn2:Myt1L) resulted in a more sharply enhanced reprogramming efficiency in the NEP group compared to BEP by day 7 post-transfection (Fig. 3A) . Moreover, altering the molar ratio of BAM also led to increased neuronal morphological complexity (Fig. 3I) . BEP-treated MEFs, instead, showed no clear change in morphology in response to the altered BAM ratio. We conclude that the NEP technology is a better-suited approach not only for enhanced but also for more controlled transfection and enhanced reprogramming. We also note that current technologies, including BEP and viral-based technologies, cannot achieve such tailorable reprogramming.
Prior studies have shown that specific neuronal traits could be induced by including additional proneural genes in the reprogramming cocktail 15 . Efficient multi-factor delivery, however, is extremely challenging with viral or non-viral transfection technologies. NEP on the other hand has the ability to deliver such complex combinations in a more deterministic manner at the single cell level. The unique control that NEP provides when transfecting multiple plasmids allows the rapid and well-controlled screening of many transcription factor combinations for desired phenotypes following direct reprogramming. As our model, we used information from the mammalian embryonic hindbrain development, which has a wellcharacterized gradient of dorsal-ventral and rostro-caudal patterning genes. We identified and selected additional proneural transcription factors, PHOX2B, PHOX2A, and RUNX3 that are involved in patterning of autonomic hindbrain neurons 16, 17 . Plasmids encoding for such factors, in combination with BAM, were then NEP-transfected into MEFs. Transfected cultures were then analyzed for marker expression and morphometry. Our results showed a slight increase in reprogramming efficiency by day 14 after transfection for the BAM/PHOX2B/PHOX2A/RUNX3 group relative to BAM only (mean iN reprogramming efficiency = 12% for BAM-PPR and 9% for BAM alone, Fig. S2 ). As such, our approach achieved reprogramming efficiencies comparable to viral methodologies but without the constraints of capsid size, and with the ability to control plasmid dosage at the single cell level. We therefore analyzed neuronal maturity by morphometric analyses. Morphometric analyses of the iNs showed the most marked changes between groups, with iNs from the six-factor cocktail exhibiting more complex and mature neuronal morphologies compared to BAM alone. We conclude that NEP can improve the quality of neuronal reprogramming by increasing the morphological complexity of the neurons generated. Furthermore, since adding additional neuronal proneural genes resulted in only a modest, albeit significant, increase in neuronal reprogramming efficiency, we conclude that several barriers exist to the efficient generation of induced neurons that are not solved by more deterministic plasmid delivery.
NEP helps probe and uncover novel stochastic barriers to iN formation
Although NEP-based transfection ultimately resulted in relatively high reprogramming efficiencies, comparable to viral methodologies, a considerable proportion of MEFs appear to be less amenable to reprogramming. We thus designed experiments to determine cellular mechanistic barriers to direct neuronal reprogramming. Our time-lapse monitoring of BAM/NEP-treated MEFs is illustrated in Fig. 4 and in videos 1-4 in the Supplemental Material.
Instances of cells showing neuronal morphology could be identified as early as 15 hours post-NEP (Fig. 4A) . We note that some cells showed rapid and selective plasmid silencing ( Supplementary Video 2 and Fig 4) , and that some cells also underwent divisions coupled with asymmetric plasmid inheritance after a division (Fig. 4) . We thus proceeded to use NEP to further probe the stochastic aspects of iN reprogramming by focusing on the cell cycle, and the potential role of alternative intermediary pathways in the reprogramming process.
Regulatory factors upstream of Ascl1 discovered by NEP
Ascl1 pioneer activity is in part mediated by the interaction (direct or indirect) with the trivalent chromatin signature that includes H3K4me1, H3K27ac, and H3K9me3 18 . Therefore, although the Ascl1 DNA consensus site clearly plays a key role, Ascl1 pioneer activity would require additional factors capable of sensing certain chromatin states. We therefore utilized the NEP platform to explore the potential roles of the S-phase cyclin CCNA2 in neuronal reprogramming. CCNA2 has a well-established, albeit somewhat unappreciated role, in chromatin regulation. First, in S-phase, the chromatin landscape undergoes dramatic alterations as the entire genome is duplicated. CCNA2's role as an initiator of replication origin 19 thus insinuates a role as a chromatin sensor. With this in mind, we isolated MEFs from pups harboring a homozygous targeted CCNA2 allelle that undergoes ablation after cre-mediated recombination. We used two methods to ablate the CCNA2 locus. CCNA2 fl/fl MEFs were either infected with an adenovirus-cre (or adenovirus-Lacz as a negative control) after BAM NEP resulting in cre expression several hours after BAM expression (Fig. 5) , or directly co-transfected with a pCag-cre plasmid resulting in simultaneous cre expression in the presence of BAM. The cells were kept in culture for 14 days and the extent of reprogramming was measured in terms of -tubulin III expression (Fig. 5A-D 
NEP discovers alternative intermediary pathways in the reprogramming process
Our findings of an S-phase cyclin as a potential pathway component of BAM-mediated reprogramming raise the possibility that at least a subset of reprogramming cells undergo Sphase. As this is improbable for mature neurons, we postulated that during the transition some somatic cells may first revert to a neural progenitor phase, followed by cell amplification and/or 13 differentiation. A limited number of studies with conflicting results have looked into the potential role intermediate progenitor-like stages (i.e., neural progenitor cells) could play in BAM-mediated iN reprogramming 20 . To further probe this, we evaluated mRNA expression of the neural stem cell marker nestin in MEFs 24 h after NEP-based delivery of either the Ascl1 plasmid alone, or co-transfected with Brn2 and Myt1l. We found that Ascl1 plasmid transfection dosage correlated with nestin mRNA levels (Fig. 6) . Moreover, dose-controlled delivery of BAM by NEP showed a significant increase in nestin expression, which positively correlated with exogenous Ascl1 delivery/expression (Fig. 6B) . In addition, immunostaining results 14 days after NEP-based delivery of BAM showed a number of nestin-positive cells that were still actively expressing exogenous Ascl1/GFP (Fig. 6A) .
In order to further determine if a subset of the neurons resulting from NEP/BAM-mediated reprogramming underwent a transient neural stem cell phase, we generated MEFs carrying the following two loci: Nestin-cre-ER, and Rosa mTdTomato/mGFP . These MEFs express membranebound TdTomato in the absence of cre, whereas cells expressing a membrane-bound GFP indicate that cre-mediated excision occurred at some point in their ancestry. MEFs were treated with 1 M 4-OH to stimulate the CRE-ER construct and cells underwent BAM-mediated reprogramming by NEP. In this case we used BAM plasmids that did not carry a fluorescent reporter gene. 4-OH was maintained in the culture media throughout the reprogramming process. Cells at 1, 7 and 14 days were fixed in 4% paraformaldehyde, and neuronal reprogramming of GFP-positive cells was determined. These conditions showed a significant increase in the number of GFP-positive cells (Fig. 6C-E) . We found many GFP-positive neurons, indicating that the cells had passed through a nestin-positive stage (Fig. 6F) . We Although the inclusion of multicistronic expression vectors or translated products capable of TEVP-mediated proteolysis theoretically can aid in controlling the ratios of reprogramming factors, they are fraught with caveats. First, the molar ratios achieved by implementing these methodologies will always be equimolar. Our data demonstrating that increased AsclI relative to Brn2 and MytlI increases neuronal nuclear reprogramming efficiency and increases neuronal complexity underscore the importance of controlling relative levels of reprogramming genes during this process. Furthermore, NEP technology is not constrained to plasmid DNA delivery. Indeed, any charged molecule , including drugs, miRNA 22 , or RNA implicated in reprogramming 23 , can be delivered using NEP. Although viral based gene delivery methodologies such as Sendai virus may have unique advantages, viral gene delivery will always be constrained by capsid size; such constraints are not applicable to NEP. Plasmid size constraints hinder efficiency of gene editing tools such as dCas9, which are often over 9 kb in size 24 .
Stochastic Barriers to Efficient Neuronal Nuclear Reprograming
Somatic cell reprogramming into iPS cells has some technical advantages over neuronal reprogramming. Specifically, the fact that iPS cells have a significant proliferative potential indicates that they are amenable to clonal dilution and colony picking. In contrast, somatic cell reprogramming into neurons will ultimately require a high throughput methodology to generate neurons in sufficient quantities for regenerative medicine applications. With NEP technology, we are uniquely capable of delivering in a benign fashion a precise dosage of reprogramming factors. Our findings show that NEP is an improved electroporation strategy relative to BEP in that we are capable of producing more neurons, NEP induced neurons display more complexly arborized neurites relative to bulk electroporation, and the reprogramming occurs faster.
Nevertheless, with NEP we found that not all of the cells reprogrammed into neurons, and that induced neuron formation occurred at different rates, despite receiving more uniform quantities of plasmid DNA compared to BEP. Our data show that exogenous Ascl1 transcripts may be endogenously silenced more rapidly than other factors, and that some cells undergo neuronal reprogramming more rapidly than others. Furthermore, the dependency of S-phase cyclins for reprogramming research underscore a potential prominent role of the cell cycle regulatory genes. Thus, NEP BAM-mediated neuronal reprogramming has several stochastic barriers downstream of the plasmid delivery that must be overcome. Indeed, these data are in keeping with the stochastic nature of OSKM-mediated somatic cell reprogramming into iPS cells 25 .
Ascl1 has been recently identified as the pioneer factor for neuronal reprogramming 18 .
We have shown, for the first time, that uniform expression of BAM reprogramming factors alone does not guarantee neuronal reprogramming from MEFs. Our finding showing selective depletion of exogenous Ascl1 transcription in some cells is in keeping with the notion that robust Ascl1 expression is required for neuronal reprogramming. Indeed, endogenous silencing of exogenous Ascl1 transcription seems to play a role in maintaining the stochastic nature to BAMmediated neuronal reprogramming. Unraveling the mechanisms of this endogenous barrier may allow the acceleration of synchronous and deterministic neuronal reprogramming as has been shown in iPS cell reprogramming paradigms 26 . Nevertheless, the cellular mechanisms by which Ascl1 promotes neuronal reprogramming are unknown. In the chick developing neural tube, exogenous murine Ascl1 expression accelerates neuronal differentiation with concomitant cell cycle exit 27 . In contrast, in the murine ventral telencephalon, several pro-proliferative genes are enhanced directly by Ascl1, including several G1/S and G2/M-transition proteins; these genes are activated prior to classical Ascl1-associated genes implicated in neuronal specification with cell cycle exit 28 . It is therefore not surprising that targeted ablation of the S-phase gene CCNA2 early during neuronal reprogramming hampers iN formation. These data suggest that early during the process, at least some reprogramming cells may require DNA replication, which is a known modifier of epigenetic signatures 29 . Furthermore, our data suggest that at least a subset of reprogrammed neurons proceed to a nestin-positive progenitor cell stage. In summary, our NEP platform has generated a framework upon which future experiments can be efficiently designed to dissect the molecular underpinnings of nuclear reprogramming and neuronal cellular maturity. Our novel biological findings uncover stochastic cellular mechanisms that explain to some extent the inefficiencies of induced neuron formation. 
